Balapiravir plus peginterferon alfa-2a (40KD)/ribavirin in a randomized trial of hepatitis C genotype 1 patients(♦)
David R. Nelson
, Stefan Zeuzem†, Pietro Andreone‡, Peter Ferenci§, Robert Herring||, Donald M. Jensen¶, Patrick Marcellin**, Paul J. Pockros††, Maribel Rodríguez-Torres‡, Lorenzo Rossaro§§, Vinod K. Rustgi||||, Thomas Sepe¶, Mark Sulkowski***, Isaac R. Thomason†††, Eric M. Yoshida‡‡‡, Anna Chan§§§, George Hill||||||
,
Corresponding author
* Division of Gastroenterology, Hepatology, and Nutrition, University of Florida, Gainsville, USA
† Department of Medicine, J.W. Goethe University Hospital, Frankfurt, Germany
‡ Dipartimento di Medicina Clinica, Università di Bologna, Bologna, Italy
§ Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
|| Nashville Gastrointestinal Specialists Inc, Nashville, USA
¶ Center for Liver Diseases, Chicago, Section of Gastroenterology, Hepatology and Nutrition, University of Chicago Medical Center, USA
** Hôpital Beaujon, Clinchy, France
†† Division of Gastroenterology and Hepatology, The Scripps Clinic, Torrey Pines, USA
‡‡ Fundacion de Investigacion De Diego Santurce, Puerto Rico and Ponce School of Medicine, Puerto Rico, USA
§§ Division of Gastroenterology and Hepatology, University of California, Davis Medical Center, Sacramento, USA
|||| Georgetown University Medical Center, Fairfax, VA, USA
¶¶ University Gastroenterology, Providence, USA
*** Viral Hepatitis Center in the Divisions of Infectious Diseases and Gastroenterology/Hepatology, Johns Hopkins University School of Medicine, Baltimore, USA
††† Mountain West Gastroenterology, Transplant Department, Intermountain Medical Center, Salt Lake City, USA
‡‡‡ Division of Gastroenterology, University of British Columbia, Vancouver, BC, Canada
§§§ Roche, Nutley, NJ, USA
|||||| Roche, Palo Alto, CA, USA
Ver másRead
1740
Timeswas read the article
448
Total PDF
1292
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 9 | 5 | 14 |
| 2025 11 | 59 | 48 | 107 |
| 2025 10 | 19 | 23 | 42 |
| 2025 9 | 25 | 12 | 37 |
| 2025 8 | 32 | 16 | 48 |
| 2025 7 | 52 | 34 | 86 |
| 2025 6 | 62 | 2 | 64 |
| 2025 5 | 24 | 7 | 31 |
| 2025 4 | 28 | 7 | 35 |
| 2025 3 | 26 | 3 | 29 |
| 2025 2 | 28 | 3 | 31 |
| 2025 1 | 30 | 4 | 34 |
| 2024 12 | 20 | 1 | 21 |
| 2024 11 | 20 | 4 | 24 |
| 2024 10 | 5 | 3 | 8 |
| 2024 9 | 6 | 1 | 7 |
| 2024 8 | 5 | 1 | 6 |
| 2024 7 | 8 | 2 | 10 |
| 2024 6 | 5 | 2 | 7 |
| 2024 5 | 7 | 2 | 9 |
| 2024 4 | 7 | 4 | 11 |
| 2024 3 | 11 | 3 | 14 |
| 2024 2 | 5 | 4 | 9 |
| 2024 1 | 10 | 5 | 15 |
| 2023 12 | 7 | 10 | 17 |
| 2023 11 | 3 | 3 | 6 |
| 2023 10 | 7 | 4 | 11 |
| 2023 9 | 12 | 3 | 15 |
| 2023 8 | 13 | 3 | 16 |
| 2023 7 | 5 | 2 | 7 |
| 2023 6 | 21 | 3 | 24 |
| 2023 5 | 43 | 1 | 44 |
| 2023 4 | 34 | 0 | 34 |
| 2023 3 | 26 | 0 | 26 |
| 2023 2 | 26 | 3 | 29 |
| 2023 1 | 6 | 1 | 7 |
| 2022 12 | 12 | 3 | 15 |
| 2022 11 | 14 | 4 | 18 |
| 2022 10 | 14 | 6 | 20 |
| 2022 9 | 10 | 4 | 14 |
| 2022 8 | 25 | 7 | 32 |
| 2022 7 | 24 | 5 | 29 |
| 2022 6 | 37 | 5 | 42 |
| 2022 5 | 27 | 6 | 33 |
| 2022 4 | 29 | 7 | 36 |
| 2022 3 | 22 | 6 | 28 |
| 2022 2 | 11 | 3 | 14 |
| 2022 1 | 44 | 5 | 49 |
| 2021 12 | 23 | 8 | 31 |
| 2021 11 | 17 | 6 | 23 |
| 2021 10 | 35 | 8 | 43 |
| 2021 9 | 31 | 9 | 40 |
| 2021 8 | 47 | 5 | 52 |
| 2021 7 | 8 | 10 | 18 |
| 2021 6 | 6 | 7 | 13 |
| 2021 5 | 11 | 5 | 16 |
| 2021 4 | 40 | 15 | 55 |
| 2021 3 | 12 | 7 | 19 |
| 2021 2 | 5 | 8 | 13 |
| 2021 1 | 4 | 7 | 11 |
| 2020 12 | 5 | 9 | 14 |
| 2020 11 | 6 | 5 | 11 |
| 2020 10 | 10 | 2 | 12 |
| 2020 9 | 7 | 2 | 9 |
| 2020 8 | 2 | 1 | 3 |
| 2020 7 | 3 | 1 | 4 |
| 2020 6 | 4 | 2 | 6 |
| 2020 5 | 2 | 3 | 5 |
| 2020 4 | 3 | 0 | 3 |
| 2020 3 | 9 | 7 | 16 |
| 2020 2 | 3 | 2 | 5 |
| 2020 1 | 7 | 3 | 10 |
| 2019 12 | 9 | 4 | 13 |
| 2019 11 | 2 | 4 | 6 |
| 2019 10 | 0 | 5 | 5 |
| 2019 9 | 4 | 4 | 8 |
| 2019 8 | 1 | 2 | 3 |
| 2019 7 | 0 | 3 | 3 |
| 2019 6 | 1 | 4 | 5 |
Show all
